Skip to content
10-K

Annual Report

CARGO Therapeutics, Inc.

0000950170-25-037929

← back to feed
Filed
Mar 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 5, 2025 46.05M sh
Shares Diluted FY 2024 · Dec 31, 2024 44.97M sh
Shares Diluted FY 2024 · Dec 31, 2023 5.94M sh
Capex FY 2024 · Dec 31, 2024 $4.45M
Capex FY 2024 · Dec 31, 2023 $8.28M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$139.74M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$81.16M
Cash And Equivalents FY 2024 · Dec 31, 2024 $64.38M
Cash And Equivalents FY 2024 · Dec 31, 2023 $405.73M
Stockholders Equity FY 2024 · Dec 31, 2024 $360.23M
Stockholders Equity FY 2024 · Dec 31, 2023 $405.39M
Stockholders Equity FY 2024 · Dec 31, 2022 −$35.24M
Current Liabilities FY 2024 · Dec 31, 2024 $25.03M
Current Liabilities FY 2024 · Dec 31, 2023 $21.16M
Total Liabilities FY 2024 · Dec 31, 2024 $53.83M
Total Liabilities FY 2024 · Dec 31, 2023 $47.65M
Current Assets FY 2024 · Dec 31, 2024 $345.01M
Current Assets FY 2024 · Dec 31, 2023 $409.48M
Total Assets FY 2024 · Dec 31, 2024 $414.05M
Total Assets FY 2024 · Dec 31, 2023 $453.04M
Eps Diluted FY 2024 · Dec 31, 2024 −$3.72
Eps Diluted FY 2024 · Dec 31, 2023 −$16.53
Eps Basic FY 2024 · Dec 31, 2024 −$3.72
Eps Basic FY 2024 · Dec 31, 2023 −$16.53
Sga Expense FY 2024 · Dec 31, 2024 $43.97M
Sga Expense FY 2024 · Dec 31, 2023 $20.92M
Rd Expense FY 2024 · Dec 31, 2024 $143.4M
Rd Expense FY 2024 · Dec 31, 2023 $75.79M
Net Income FY 2024 · Dec 31, 2024 −$167.5M
Net Income FY 2024 · Dec 31, 2023 −$98.15M
Operating Income FY 2024 · Dec 31, 2024 −$187.37M
Operating Income FY 2024 · Dec 31, 2023 −$96.71M